Abstract:
Bronchial asthma is a chronic inflammatory disease of the airways, characterized by variable airflow
obstruction and bronchial hyperresponsiveness. In recent years, increasing attention has been given to the role of infectious
agents and connective tissue dysplasia in the pathogenesis, clinical course, and treatment outcomes of bronchial asthma.
This abstract highlight modern diagnostic strategies that incorporate the identification of infectious triggers, as well
as structural abnormalities associated with connective tissue dysplasia, particularly in pediatric patients. Therapeutic
approaches now emphasize personalized medicine, targeting underlying dysplastic changes and optimizing anti-inflammatory
and antimicrobial therapies. Early identification of comorbid conditions, including connective tissue dysplasia-related
anomalies, is crucial for effective asthma control and improved quality of life. Integrating multidisciplinary methods
enhances both diagnostic accuracy and therapeutic efficacy in managing bronchial asthma with complex etiological
backgrounds.
